Since 2004, our company has specialized in scientific research and the development of next-generation biotechnology products (including pharmaceuticals and vaccines). Over the years, we have successfully fulfilled numerous state contracts involving fundamental and applied research, including projects for the Ministry of Defense of the Russian Federation and the Federal Medical-Biological Agency of Russia (FMBA).

We are permanent members of the All-Russian Society of Inventors and Rationalizers (VOIR), multiple laureates of the “Opora Rossii” award, winners of Rospatent’s “Best Invention” title, and holders of Grand Prix awards as well as dozens of trophies and medals from international exhibitions and competitions in innovation and emerging technologies.

We develop and synthesize PNA, LNA, and gamma-AA peptides for application in cancer therapies.

We specialize in antiviral agents and monoclonal antibody development. Our team has proven experience in executing successful research projects in the fields of CRISPR/Cas systems, chimeric antigen receptor design (CAR-T), and lentiviral-based delivery systems.

In practice, we provide services including the synthesis and cloning of genetic constructs, peptide synthesis, recombinant protein and plasmid DNA preparation and purification, as well as characterization and quality assessment of biological samples. In addition, we develop cosmetic products based on recombinant proteins, as well as highly effective specialized nutrition supplements and nutraceuticals.

About the Company

Molecular design and genetic engineering of recombinant protein molecules (native as well as chimeric proteins with specified properties) and DNA constructs (expression vectors, vectors for DNA vaccines, etc.).